Growth Financing Despite a small team, myBiometry has secured a total funding of 13M and recently raised a 5M seed round in 2024, indicating investor confidence and potential for accelerated product development and enterprise sales.

Healthcare Focus The company targets remote monitoring of chronic conditions with an initial emphasis on asthma, offering an opportunity to upsell to broader chronic disease management solutions and sensor-enabled telemetry to hospitals and payers.

Enterprise Readiness Leveraging a cloud-based stack including Azure AD, Office 365, and secure DNS services positions myBiometry as enterprise-friendly, suggesting it can integrate with existing healthcare IT ecosystems and data governance requirements.

Analytics & Compliance Use of Google Analytics and security-first measures like HSTS and Cloudflare Bot Management signals a data-driven approach and attention to protection of patient data, a critical selling point for health system procurement.

Scale & Partnerships Current revenue range and modest headcount imply room to scale through channel partnerships, system integrators, and collaborations with larger medical device or EHR players to accelerate market entry.